CANDONILIMAB

Clinical trials for CANDONILIMAB explained in plain language.

Never miss a new study

Get alerted when new CANDONILIMAB trials appear

Sign up with your email to follow new studies for CANDONILIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat bile duct cancer

Disease control Ongoing

This study is testing a new combination of two drugs, candonilimab and LM-302, for people with advanced bile duct cancer that has continued to grow despite standard chemotherapy and immunotherapy. The goal is to see if this combination can shrink tumors and control the disease fo…

Matched conditions: CANDONILIMAB

Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

CANDONILIMAB

Get alerted when new CANDONILIMAB trials appear

New hope for Tough-to-Treat bile duct cancer